[Image: Kyle vs Leukemia, the sequel]

About This Fundraiser

On April 27, 2010 Kyle was admitted to the hospital where he was diagnosed with acute lymphocytic leukemia, just a few weeks before his 16th birthday. We are fortunate to have medical insurance and he went through a 3.5 year treatment before achieving remission. We are grateful for all the support and care he received during his treatment. Kyle completed high school and enrolled in community college to begin the journey of becoming a nurse. Working full time and going to school he felt like he had his life back and was busy catching up. Ever the positive person he said that it was easy compared to having cancer.

On Nov 27, 2014 Thanksgiving morning he was taken to the emergency department with an infection in his hand that developed overnight. It was there he learned that the leukemia was back. He started chemotherapy within days and was scheduled to get a bone marrow transplant.

Now he faces another hurdle. The chemotherapy is not working well enough to get his counts down to have a bone marrow transplant. The oncologist is working to get him in a CAR T-Cell Therapy clinical study in Seattle, WA. This is cutting edge cancer research and treatment and only for patients that have relapsed and not responding to chemotherapy.

Seattle Children's Hospital Clinical Trials T-Cell Therapy Overview

A Possible Option Where None Had Existed

"More than 80 percent of children who are diagnosed with ALL that arises in B cells—the predominant type of pediatric ALL—will be cured by intensive chemotherapy.

For patients whose cancers return after intensive chemotherapy or a stem cell transplant, the remaining treatment options are “close to none,” said Stephan Grupp, M.D., Ph.D., of the Children’s Hospital of Philadelphia (CHOP) and the lead investigator of a trial testing CAR T cells primarily in children with ALL. This treatment may represent a much-needed new option for such patients, he said.

Trials of CAR T cells in adults and children with leukemia and lymphoma have used T cells engineered to target the CD19 antigen, which is present on the surface of nearly all B cells, both normal and cancerous."

We created this CauseWish to raise funds to help pay for transportation, lodging, and other expenses while Kyle is being treated in WA. He will have to go up there multiple times and have several extended stays in the hospital while there. The last stay will be 1-2 months while his body adjusts to the treatment. Any amount you can contribute will help and will be greatly appreciated.

Kyle’s adventures

well-wishers
92
donated of $8,000.00 goal
$11,205.00

140% Funded
raised offline
$316.00

Funding Successful!

Fundraiser by

  1. Updated posted by KylesDad On Mar 18, 2015

    Harvest is done!

    T cells all shipped out to the lab. Part 1 in the books!

    Comments

    Please login to post comment

     
  2. Updated posted by KylesDad On Mar 03, 2015

    Treatment starting next week!

    We have dates confirmed for Seattle, treatment will start next Tuesday! Thank you to everyone who has supported this endeavor. Please keep Kyle in your thoughts and prayers.

    Comments

    Please login to post comment

     
  3. Updated posted by KylesDad On Feb 12, 2015

    2/12 update

    Kyle is in the hospital for the next two weeks receiving four days of intensive ARA-C and Erwinia chemotherapy to keep the cancer from gaining any ground, then 10 days of recovery before heading off to Seattle in March to start the CAR T-cell trial.

    Many thanks to all who have contributed and left supportive notes...you are making a difference!

    take care everyone,

    the Waldens

    Comments

    Please login to post comment